NextCure Launches New GLP Lab, Expands In-House Capabilities

Published on :

For NextCure, a fast-growing, publicly-traded (Nasdaq: NXTC) clinical-stage biotech located in Beltsville, Maryland, choosing to invest in and build capabilities in-house aligned with its mission to serve patients that do not respond to existing therapies. 

NextCure Featured on Business Spotlight Video Series

Published on :

NextCure, an emerging global leader in developing novel immunomedicines to treat cancer and other immune-related diseases, was recently featured on Prince George’s County Economic Development Corporation’s (PGCEDC) Business Spotlight video series.